Clinical Trials Logo

Filter by:
NCT ID: NCT01506882 Completed - Epilepsy Clinical Trials

An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy

Start date: December 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of Levetiracetam (LEV) used as monotherapy, with efficacy measured as 6-month seizure freedom at the last evaluated dose in the LEV 1000 mg/day to 2000 mg/day group, in newly or recently diagnosed epilepsy subjects.

NCT ID: NCT01506856 Completed - Clinical trials for Fallopian Tube Cancer

Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial

iPocc
Start date: May 2010
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is: Phase A: To confirm the feasibility of paclitaxel administered by intravenous (IV) infusion weekly plus concurrent carboplatin administered by intraperitoneal (IP) injection once every 3 weeks (dd-TCip therapy). Phase B: To compare the efficacy and safety of the following two treatment regimens as first-line chemotherapy in women with epithelial ovarian, Fallopian tube or primary peritoneal cancer.

NCT ID: NCT01506752 Completed - Healthy Adult Clinical Trials

A Bioequivalence Study Comparing Improved Versus Current Orally Disintegrating E2020 10 mg Tablet in Healthy Japanese Adult Males

Start date: July 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate the bioequivalence of improved and current orally disintegrating E2020 10 mg tablets as a single dose in Japanese healthy adult males for each of two administration methods (with/without water).

NCT ID: NCT01506739 Completed - Healthy Adult Clinical Trials

A Bioequivalence Study of Film-coated Tablet and Dry Syrup 1% Form for E2020 in Healthy Japanese Adult Males

Start date: March 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to confirm bioequivalence between E2020 dry syrup 1% form (0.5 g), given either with 200 mL of water or suspended in 20 mL of water, and E2020 film-coated tablet (5 mg) in Japanese healthy adult males.

NCT ID: NCT01505127 Completed - H. Pylori Infection Clinical Trials

Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori

Start date: January 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to confirm the efficacy of triple therapy with TAK-438, Amoxicillin and Clarithromycin, twice daily (BID) by demonstrating its non-inferiority to triple therapy with Lansoprazole, Amoxicillin and Clarithromycin in H. pylori-positive patients with scarred gastric or duodenal ulcers.

NCT ID: NCT01504412 Completed - Pain Clinical Trials

Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy

Start date: January 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate the effectiveness and safety of DS-5565, compared to placebo, in subjects with pain associated with diabetic peripheral neuropathy.

NCT ID: NCT01501786 Completed - Clinical trials for Congenital Heart Disease

Does Ketamine Attenuate Depression of Respiratory and Cardiac Functions

Start date: January 2012
Phase: N/A
Study type: Interventional

Normal cardiac and respiratory functions should be maintained during pediatric cardiac catheterization. Propofol has become a popular choice for sedation in children, however, it depresses cardiac and respiratory functions. Some investigators reported that ketamine attenuates its depressant effect, but it remains unclear whether ketamine reduces cardiac and respiratory depression caused by propofol in pediatric cardiac catheterization.

NCT ID: NCT01501266 Completed - Breast Cancer Clinical Trials

Faslodex Specific Clinical Experience Investigation

Start date: February 2012
Phase: N/A
Study type: Observational

The purpose of this study is to confirm the safety profile such as the frequency of serious adverse events or any unexpected adverse events and overall efficacy of Faslodex for long term treatment in daily clinical practice.

NCT ID: NCT01500434 Completed - Clinical trials for Coronary Artery Disease

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)

PLATINUM LL
Start date: February 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of the PROMUS Elementâ„¢ Everolimus-Eluting Coronary Stent System for the treatment of patients with up to 2 de novo atherosclerotic coronary artery lesions. The lesions can be longer than average-sized.

NCT ID: NCT01498692 Completed - Clinical trials for Coronary Artery Disease

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels

PLATINUM SV
Start date: February 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of the PROMUS Elementâ„¢ Everolimus-Eluting Coronary Stent System for the treatment of patients with up to 2 de novo atherosclerotic coronary artery lesions. The lesions can be located in vessels that are smaller than average-sized.